Jane Norma Winter

  • 8152 Citations
1983 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2014

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Tzankov, A., Xu-Monette, Z. Y., Gerhard, M., Visco, C., Dirnhofer, S., Gisin, N., Dybkaer, K., Orazi, A., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Ponzoni, M., Ferreri, A. J. M., Ye, Q., Winter, J. N., Farnen, J. P., Piris, M. A., Møller, M. B. & 4 others, You, M. J., Mcdonnell, T., Medeiros, L. J. & Young, K. H., Jul 2014, In : Modern Pathology. 27, 7, p. 958-971 14 p.

Research output: Contribution to journalArticle

81 Scopus citations

Transformed Lymphoma

Doucet, S. & Winter, J. N., Jun 20 2014, Cancer Consult: Expertise for Clinical Practice. Wiley Blackwell, p. 295-303 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2013

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma

Hay, A. E., Klimm, B., Chen, B. E., Goergen, H., Shepherd, L. E., Fuchs, M., Gospodarowicz, M. K., Borchmann, P., Connors, J. M., Markova, J., Crump, M., Lohri, A., Winter, J. N., Dörken, B., Pearcey, R. G., Diehl, V., Horning, S. J., Eich, H. T., Engert, A. & Meyer, R. M., Dec 1 2013, In : Annals of Oncology. 24, 12, p. 3065-3069 5 p., mdt389.

Research output: Contribution to journalArticle

37 Scopus citations

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas

Evens, A. M., Rosen, S. T., Helenowski, I., Kline, J., Larsen, A., Colvin, J., Winter, J. N., van Besien, K. M., Gordon, L. I. & Smith, S. M., Oct 1 2013, In : British Journal of Haematology. 163, 1, p. 55-61 7 p.

Research output: Contribution to journalArticle

33 Scopus citations

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma

Stiff, P. J., Unger, J. M., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., Miller, T. P., Tubbs, R. R., Marcellus, D., Friedberg, J. W., Barton, K. P., Mills, G. M., LeBlanc, M., Rimsza, L. M., Forman, S. J. & Fisher, R. I., Jan 1 2013, In : New England Journal of Medicine. 369, 18, p. 1681-1690 10 p.

Research output: Contribution to journalArticle

191 Scopus citations

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: A phase i trial of combined induction therapy and bortezomib consolidation

Roy, R., Evens, A. M., Patton, D., Gallot, L., Larson, A., Rademaker, A., Cilley, J., Spies, S., Variakojis, D., Gordon, L. I. & Winter, J. N., Mar 1 2013, In : Leukemia and Lymphoma. 54, 3, p. 497-502 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: A report from the International DLBCL Rituximab-CHOP Consortium Program Study

Hu, S., Xu-Monette, Z. Y., Balasubramanyam, A., Manyam, G. C., Visco, C., Tzankov, A., Liu, W. M., Miranda, R. N., Zhang, L., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Han van Krieken, J., Huang, Q. & 15 others, Huh, J., Ai, W., Ponzoni, M., Ferreri, A. J. M., Zhao, X., Winter, J. N., Zhang, M., Li, L., Møller, M. B., Piris, M. A., Li, Y., Go, R. S., Wu, L., Medeiros, L. J. & Young, K. H., Jan 1 2013, In : Blood. 121, 14, p. 2715-2724 10 p.

Research output: Contribution to journalArticle

137 Scopus citations

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large b-cell lymphoma: Results of an international phase II trial

Armand, P., Nagler, A., Weller, E. A., Devine, S. M., Avigan, D. E., Chen, Y. B., Kaminski, M. S., Holland, H. K., Winter, J. N., Mason, J. R., Fay, J. W., Rizzieri, D. A., Hosing, C. M., Ball, E. D., Uberti, J. P., Lazarus, H. M., Mapara, M. Y., Gregory, S. A., Timmerman, J. M., Andorsky, D. & 4 others, Or, R., Waller, E. K., Rotem-Yehudar, R. & Gordon, L. I., Nov 20 2013, In : Journal of Clinical Oncology. 31, 33, p. 4199-4206 8 p.

Research output: Contribution to journalArticle

331 Scopus citations

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program

Xu-Monette, Z. Y., Møller, M. B., Tzankov, A., Montes-Moreno, S., Hu, W., Manyam, G. C., Kristensen, L., Fan, L., Visco, C., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huang, Q., Huh, J. & 13 others, Ai, W., Ponzoni, M., Ferreri, A. J. M., Wu, L., Zhao, X., Bueso-Ramos, C. E., Wang, S. A., Go, R. S., Li, Y., Winter, J. N., Piris, M. A., Medeiros, L. J. & Young, K. H., Jan 1 2013, In : Blood. 122, 15, p. 2630-2640 11 p.

Research output: Contribution to journalArticle

32 Scopus citations

Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo

Ahn, R. W., Barrett, S. L., Raja, M. R., Jozefik, J. K., Spaho, L., Chen, H., Bally, M. B., Mazar, A. P., Avram, M. J., Winter, J. N., Gordon, L. I., Shea, L. D., O'Halloran, T. V. & Woodruff, T. K., Mar 20 2013, In : PloS one. 8, 3, e58491.

Research output: Contribution to journalArticle

44 Scopus citations

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: A report from an international DLBCL rituximab-CHOP consortium program study

Visco, C., Tzankov, A., Xu-Monette, Z. Y., Miranda, R. N., Tai, Y. C., Li, Y., Liu, W. M., d'Amore, E. S. G., Li, Y., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Wang, H. Y., Dunphy, C. H., His, E. D., Zhao, X. F., Choi, W. W. L. & 16 others, Zhao, X., Han van Krieken, J., Huang, Q., Ai, W., O'Neill, S., Ponzoni, M., Ferreri, A. J. M., Kahl, B. S., Winter, J. N., Go, R. S., Dirnhofer, S., Piris, M. A., Møller, M. B., Wu, L., Medeiros, L. J. & Young, K. H., Feb 1 2013, In : Haematologica. 98, 2, p. 255-263 9 p.

Research output: Contribution to journalArticle

110 Scopus citations

Single nucleotide variation in the TP53 3′ untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: A report from the International DLBCL Rituximab-CHOP Consortium Program

Li, Y., Gordon, M. W., Xu-Monette, Z. Y., Visco, C., Tzankov, A., Zou, D., Qiu, L., Montes-Moreno, S., Dybkaer, K., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huang, Q., Ai, W., Ponzoni, M., Ferreri, A. J. M. & 9 others, Winter, J. N., Go, R. S., Piris, M. A., Møller, M. B., Wu, L., Wang, M., Ramos, K. S., Medeiros, L. J. & Young, K. H., May 30 2013, In : Blood. 121, 22, p. 4529-4540 12 p.

Research output: Contribution to journalArticle

30 Scopus citations
2012

ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma

Meyer, R. M., Gospodarowicz, M. K., Connors, J. M., Pearcey, R. G., Wells, W. A., Winter, J. N., Horning, S. J., Dar, A. R., Shustik, C., Stewart, D. A., Crump, M., Djurfeldt, M. S., Chen, B. E. & Shepherd, L. E., Feb 2 2012, In : New England Journal of Medicine. 366, 5, p. 399-408 10 p.

Research output: Contribution to journalArticle

264 Scopus citations

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study

Visco, C., Li, Y., Xu-Monette, Z. Y., Miranda, R. N., Green, T. M., Li, Y., Tzankov, A., Wen, W., Liu, W. M., Kahl, B. S., D'Amore, E. S. G., Montes-Moreno, S., Dybkær, K., Chiu, A., Tam, W., Orazi, A., Zu, Y., Bhagat, G., Winter, J. N., Wang, H. Y. & 22 others, O'Neill, S., Dunphy, C. H., Hsi, E. D., Zhao, X. F., Go, R. S., Choi, W. W. L., Zhou, F., Czader, M., Tong, J., Zhao, X., Van Krieken, J. H., Huang, Q., Ai, W., Etzell, J., Ponzoni, M., Ferreri, A. J. M., Piris, M. A., Møller, M. B., Bueso-Ramos, C. E., Medeiros, L. J., Wu, L. & Young, K. H., Sep 1 2012, In : Leukemia. 26, 9, p. 2103-2113 11 p.

Research output: Contribution to journalArticle

226 Scopus citations

Hodgkin lymphoma, version 2.2012: Featured updates to the NCCN guidelines

Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Bello, C. M., Bierman, P. J., Blum, K. A., Chen, R., Dabaja, B., Duron, Y., Forero, A., Gordon, L. I., Hernandez-Ilizaliturri, F. J., Hochberg, E. P., Maloney, D. G., Mansur, D., Mauch, P. M., Metzger, M., Moore, J. O. & 7 others, Morgan, D., Moskowitz, C. H., Poppe, M., Pro, B., Winter, J. N., Yahalom, J. & Sundar, H., May 1 2012, In : JNCCN Journal of the National Comprehensive Cancer Network. 10, 5, p. 589-597 9 p.

Research output: Contribution to journalReview article

70 Scopus citations

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: Report from an International DLBCL Rituximab-CHOP Consortium Program Study

Xu-Monette, Z. Y., Wu, L., Visco, C., Tai, Y. C., Tzankov, A., Liu, W. M., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Zhao, X. F., Choi, W. W. L., Zhao, X., Van Krieken, J. H., Huang, Q., Huh, J. & 16 others, Ai, W., Ponzoni, M., Ferreri, A. J. M., Zhou, F., Kahl, B. S., Winter, J. N., Xu, W., Li, J., Go, R. S., Li, Y., Piris, M. A., Møller, M. B., Miranda, R. N., Abruzzo, L. V., Medeiros, L. J. & Young, K. H., Nov 8 2012, In : Blood. 120, 19, p. 3986-3996 11 p.

Research output: Contribution to journalArticle

162 Scopus citations
2011
23 Scopus citations

Hodgkin lymphoma: Clinical practice guidelines in oncology

Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Bello, C. M., Bierman, P. J., Blum, K. A., Dabaja, B., Duron, Y., Forero, A., Gordon, L. I., Hernandez-Ilizaliturri, F. J., Hochberg, E. P., Maloney, D. G., Mansur, D., Mauch, P. M., Metzger, M., Moore, J. O., Morgan, D., Moskowitz, C. H. & 5 others, Poppe, M., Pro, B., Weiss, L., Winter, J. N. & Yahalom, J., Sep 1 2011, In : JNCCN Journal of the National Comprehensive Cancer Network. 9, 9, p. 1020-1058 39 p.

Research output: Contribution to journalReview article

36 Scopus citations

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

Schuster, S. J., Neelapu, S. S., Gause, B. L., Janik, J. E., Muggia, F. M., Gockerman, J. P., Winter, J. N., Flowers, C. R., Nikcevich, D. A., Sotomayor, E. M., McGaughey, D. S., Jaffe, E. S., Chong, E. A., Reynolds, C. W., Berry, D. A., Santos, C. F., Popa, M. A., McCord, A. M. & Kwak, L. W., Jul 10 2011, In : Journal of Clinical Oncology. 29, 20, p. 2787-2794 8 p.

Research output: Contribution to journalArticle

183 Scopus citations
2010

A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR

Lazarus, H. M., Zhang, M. J., Carreras, J., Hayes-Lattin, B. M., Ataergin, A. S., Bitran, J. D., Bolwell, B. J., Freytes, C. O., Gale, R. P., Goldstein, S. C., Hale, G. A., Inwards, D. J., Klumpp, T. R., Marks, D. I., Maziarz, R. T., McCarthy, P. L., Pavlovsky, S., Rizzo, J. D., Shea, T. C., Schouten, H. C. & 5 others, Slavin, S., Winter, J. N., van Besien, K., Vose, J. M. & Hari, P. N., Jan 1 2010, In : Biology of Blood and Marrow Transplantation. 16, 1, p. 35-45 11 p.

Research output: Contribution to journalArticle

62 Scopus citations

A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma

Koç, O. N., Redfern, C., Wiernik, P. H., Rosenfelt, F., Winter, J. N., Carter, W. D., Gold, D. P., Stewart, M. E., Ghalie, R. G. & Bender, J. F., Feb 1 2010, In : Journal of Immunotherapy. 33, 2, p. 178-184 7 p.

Research output: Contribution to journalArticle

9 Scopus citations

Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: A prospective ECOG and Southwest Oncology Group correlative study on E4494

Winter, J. N., Li, S., Aurora, V., Variakojis, D., Nelson, B., Krajewska, M., Zhang, L., Habermann, T. M., Fisher, R. I., Macon, W. R., Chhanabhai, M., Felgar, R. E., Hsi, E. D., Medeiros, L. J., Weick, J. K., Weller, E. A., Melnick, A., Reed, J. C., Horning, S. J. & Gascoyne, R. D., Apr 15 2010, In : Clinical Cancer Research. 16, 8, p. 2435-2442 8 p.

Research output: Contribution to journalArticle

21 Scopus citations

Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms: Correspondence

Bhalla, S., Gordon, L. I., David, K., Prachand, S., Singh, A. T. K., Yang, S., Winter, J. N., Guo, D., O'Halloran, T., Platanias, L. C. & Evens, A. M., Aug 1 2010, In : British Journal of Haematology. 150, 3, p. 365-369 5 p.

Research output: Contribution to journalLetter

13 Scopus citations

Hypoxia-inducible factor-1 α expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP

Evens, A. M., Sehn, L. H., Farinha, P., Nelson, B. P., Raji, A., Lu, Y., Brakman, A., Parimi, V., Winter, J. N., Schumacker, P. T., Gascoyne, R. D. & Gordon, L. I., Feb 20 2010, In : Journal of Clinical Oncology. 28, 6, p. 1017-1024 8 p.

Research output: Contribution to journalArticle

39 Scopus citations

Management of mantle cell lymphoma: Key challenges and next steps

Williams, M., Dreyling, M., Winter, J., Muneer, S. & Leonard, J., Oct 1 2010, In : Clinical Lymphoma, Myeloma and Leukemia. 10, 5, p. 336-346 11 p.

Research output: Contribution to journalReview article

10 Scopus citations

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: Outcomes and prognostic factors in the modern era

Evens, A. M., David, K. A., Helenowski, I., Nelson, B., Kaufman, D., Kircher, S. M., Gimelfarb, A., Hattersley, E., Mauro, L. A., Jovanovic, B., Chadburn, A., Stiff, P., Winter, J. N., Mehta, J., Van Besien, K., Gregory, S., Gordon, L. I., Shammo, J. M., Smith, S. E. & Smith, S. M., Feb 20 2010, In : Journal of Clinical Oncology. 28, 6, p. 1038-1046 9 p.

Research output: Contribution to journalArticle

188 Scopus citations

Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: Current status and future applications

Ahmed, S., Winter, J. N., Gordon, L. I. & Evens, A. M., Jul 1 2010, In : Leukemia and Lymphoma. 51, 7, p. 1163-1177 15 p.

Research output: Contribution to journalReview article

13 Scopus citations

Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: Results of a phase I study

Advani, A., Coiffier, B., Czuczman, M. S., Dreyling, M., Foran, J., Gine, E., Gisselbrecht, C., Ketterer, N., Nasta, S., Rohatiner, A., Schmidt-Wolf, I. G. H., Schuler, M., Sierra, J., Smith, M. R., Verhoef, G., Winter, J. N., Boni, J., Vandendries, E., Shapiro, M. & Fayad, L., Apr 20 2010, In : Journal of Clinical Oncology. 28, 12, p. 2085-2093 9 p.

Research output: Contribution to journalArticle

227 Scopus citations

Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes

O'Connor, O. A., Portlock, C., Moskowitz, C., Hamlin, P., Straus, D., Gerecitano, J., Gonen, M., Dumitrescu, O., Sarasohn, D., Butos, J., Neylon, E., Cortelli, B. M. G., Blumel, S., Evens, A. M., Zelenetz, A. D., Wright, J., Cooper, B., Winter, J. N. & Vose, J., Jan 15 2010, In : Clinical Cancer Research. 16, 2, p. 719-726 8 p.

Research output: Contribution to journalArticle

40 Scopus citations
2009

Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?

Singh, V., Krishnamurthy, J., Duffey, S., Meagher, R., Villa, M., Monreal, J., Evens, A., Frankfurt, O., Altman, J. K., Gordon, L. I., Tallman, M., Williams, S., Winter, J. N., Singhal, S. & Mehta, J., Jan 1 2009, In : Bone Marrow Transplantation. 43, 4, p. 301-305 5 p.

Research output: Contribution to journalArticle

7 Scopus citations

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

Fenske, T. S., Hari, P. N., Carreras, J., Zhang, M. J., Kamble, R. T., Bolwell, B. J., Cairo, M. S., Champlin, R. E., Chen, Y. B., Freytes, C. O., Gale, R. P., Hale, G. A., Ilhan, O., Khoury, H. J., Lister, J., Maharaj, D., Marks, D. I., Munker, R., Pecora, A. L., Rowlings, P. A. & 8 others, Shea, T. C., Stiff, P., Wiernik, P. H., Winter, J. N., Rizzo, J. D., van Besien, K., Lazarus, H. M. & Vose, J. M., Nov 2009, In : Biology of Blood and Marrow Transplantation. 15, 11, p. 1455-1464 10 p.

Research output: Contribution to journalArticle

44 Scopus citations

NCCN Task Force report: Molecular markers in leukemias and lymphomas

Radich, J. P., Zelenetz, A. D., Chan, W. C., Croce, C. M., Czuczman, M. S., Erba, H. P., Horning, S. J., Houldsworth, J., Smith, B. D., Snyder, D. S., Sundar, H. M., Wetzler, M. & Winter, J. N., Aug 18 2009, In : JNCCN Journal of the National Comprehensive Cancer Network. 7, SUPPL. 4, p. S1-S34

Research output: Contribution to journalReview article

9 Scopus citations

Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation

Mehta, J., Frankfurt, O., Altman, J., Evens, A., Tallman, M., Gordon, L., Williams, S., Winter, J., Krishnamurthy, J., Duffey, S., Singh, V., Meagher, R., Grinblatt, D., Kaminer, L. & Singhal, S., Dec 1 2009, In : Leukemia and Lymphoma. 50, 9, p. 1434-1441 8 p.

Research output: Contribution to journalArticle

18 Scopus citations

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre phase 2 clinical trial

O'Connor, O. A., Moskowitz, C., Portlock, C., Hamlin, P., Straus, D., Dumitrescu, O., Sarasohn, D., Gonen, M., Butos, J., Neylon, E., Hamelers, R., Mac-Gregor Cortelli, B., Blumel, S., Zelenetz, A. D., Gordon, L., Wright, J. J., Vose, J., Cooper, B. & Winter, J., Apr 1 2009, In : British Journal of Haematology. 145, 1, p. 34-39 6 p.

Research output: Contribution to journalArticle

59 Scopus citations

Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma

Freedman, A., Neelapu, S. S., Nichols, C., Robertson, M. J., Djulbegovic, B., Winter, J. N., Bender, J. F., Gold, D. P., Ghalie, R. G., Stewart, M. E., Esquibel, V. & Hamlin, P., Jun 20 2009, In : Journal of Clinical Oncology. 27, 18, p. 3036-3043 8 p.

Research output: Contribution to journalArticle

109 Scopus citations

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: A report of 57 cases from the Research on Adverse Drug Events and Reports project

Carson, K. R., Evens, A. M., Richey, E. A., Habermann, T. M., Focosi, D., Seymour, J. F., Laubach, J., Bawn, S. D., Gordon, L. I., Winter, J. N., Furman, R. R., Vose, J. M., Zelenetz, A. D., Mamtani, R., Raisch, D. W., Dorshimer, G. W., Rosen, S. T., Muro, K., Gottardi-Littell, N. R., Talley, R. L. & 4 others, Sartor, O., Green, D., Major, E. O. & Bennett, C. L., Nov 17 2009, In : Blood. 113, 20, p. 4834-4840 7 p.

Research output: Contribution to journalArticle

687 Scopus citations

Radioimmunoconjugates in hematopoietic stem cell transplantation

Gopal, A. K. & Winter, J. N., Oct 15 2009, Hematopoietic Stem Cell Transplantation. Bishop, M. (ed.). p. 299-315 17 p. (Cancer Treatment and Research; vol. 144).

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

The novel expanded porphyrin, motexafin gadolinium, combined with [ 90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: Preclinical findings and results of a phase I trial

Evens, A. M., Spies, W. G., Helenowski, I. B., Patton, D., Spies, S., Jovanovic, B. D., Miyata, S., Hamilton, E., Variakojis, D., Chen, J., Naumovski, L., Rosen, S. T., Winter, J. N., Miller, R. A. & Gordon, L. I., Oct 15 2009, In : Clinical Cancer Research. 15, 20, p. 6462-6471 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: Report of the pivotal phase 2 study

Rodriguez, M. A., Pytlik, R., Kozak, T., Chhanabhai, M., Gascoyne, R., Lu, B., Deitcher, S. R. & Winter, J. N., Aug 1 2009, In : Cancer. 115, 15, p. 3475-3482 8 p.

Research output: Contribution to journalArticle

98 Scopus citations

Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-hodgkin's lymphoma

Winter, J. N., Inwards, D. J., Spies, S., Wiseman, G., Patton, D., Erwin, W., Rademaker, A. W., Weitner, B. B., Williams, S. F., Tallman, M. S., Micallef, I., Mehta, J., Singhal, S., Evens, A. M., Zimmer, M., Molina, A., White, C. A. & Gordon, L. I., Apr 1 2009, In : Journal of Clinical Oncology. 27, 10, p. 1653-1659 7 p.

Research output: Contribution to journalArticle

69 Scopus citations
2008

ACR Appropriateness Criteria® on Hodgkin's Lymphoma-Favorable Prognosis Stage I and II

Das, P., Ng, A., Constine, L. S., Hodgson, D. C., Mendenhall, N. P., Morris, D. E., Yunes, M. J., Chauvenet, A. R., Hudson, M. M. & Winter, J. N., Oct 2008, In : Journal of the American College of Radiology. 5, 10, p. 1054-1066 13 p.

Research output: Contribution to journalReview article

3 Scopus citations

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: Long-term follow-up in newly diagnosed mantle cell lymphoma

Evens, A. M., Winter, J. N., Hou, N., Nelson, B. P., Rademaker, A. W., Patton, D., Singhal, S., Frankfurt, O., Tallman, M. S., Rosen, S. T., Mehta, J. & Gordon, L. I., Feb 1 2008, In : British Journal of Haematology. 140, 4, p. 385-393 9 p.

Research output: Contribution to journalArticle

39 Scopus citations

Bcl-B expression in human epithelial and nonepithelial malignancies

Krajewska, M., Kitada, S., Winter, J. N., Variakojis, D., Lichtenstein, A., Zhai, D., Cuddy, M., Huang, X., Luciano, F., Baker, C. H., Kim, H., Shin, E., Kennedy, S., Olson, A. H., Badzio, A., Jassem, J., Meinhold-Heerlein, I., Duffy, M., Schimmer, A. D., Tsao, M. & 6 others, Brown, E., Sawyers, A., Andreeff, M., Mercola, D., Krajewski, S. & Reed, J. C., May 15 2008, In : Clinical Cancer Research. 14, 10, p. 3011-3021 11 p.

Research output: Contribution to journalArticle

45 Scopus citations

CD23+ mantle cell lymphoma: A clinical pathologic entity associated with superior outcome compared with CD23- disease

Kelemen, K., Peterson, L. A. C., Helenowski, I., Goolsby, C. L., Jovanovic, B., Miyata, S., Aranha, O., Rosen, S. T., Winter, J. N., Nelson, B. P., Gordon, L. I. & Evens, A. M., Aug 1 2008, In : American journal of clinical pathology. 130, 2, p. 166-177 12 p.

Research output: Contribution to journalArticle

37 Scopus citations

Hodgkin disease/lymphoma

Hoppe, R. T., Advani, R. H., Ambinder, R. F., Bierman, P. J., Bloomfield, C. D., Blum, K., Dabaja, B., Djulbegovic, B., Forero, A., Gordon, L. I., Hernandez-Ilizaliturri, F. J., Hudson, M. M., Kaminski, M. S., Love, G., Maloney, D. G., Mansur, D., Mauch, P. M., Moore, J. O., Schilder, R. J., Weiss, L. M. & 3 others, Winter, J. N., Yahalom, J. & Zelenetz, A. D., Jul 1 2008, In : JNCCN Journal of the National Comprehensive Cancer Network. 6, 6, p. 594-622 29 p.

Research output: Contribution to journalReview article

5 Scopus citations

Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family

Evens, A. M., Schumacker, P. T., Helenowski, I. B., Singh, A. T. K., Dokic, D., Keswani, A., Kordeluk, E., Raji, A., Winter, J. N., Jovanovic, B. D., Holmgren, A., Nelson, B. P. & Gordon, L. I., Jun 1 2008, In : British Journal of Haematology. 141, 5, p. 676-680 5 p.

Research output: Contribution to journalArticle

34 Scopus citations
2007

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

Trifilio, S., Singhal, S., Williams, S., Frankfurt, O., Gordon, L. I., Evens, A., Winter, J. N., Tallman, M., Pi, J. & Mehta, J., Sep 1 2007, In : Bone Marrow Transplantation. 40, 5, p. 451-456 6 p.

Research output: Contribution to journalArticle

167 Scopus citations

Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma

Winter, J. N., Jul 1 2007, In : Current Opinion in Hematology. 14, 4, p. 360-368 9 p.

Research output: Contribution to journalReview article

11 Scopus citations

G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: Low toxicity and excellent outcomes in a 10-year analysis

Evens, A. M., Cilley, J., Ortiz, T., Gounder, M., Hou, N., Rademaker, A., Miyata, S., Catsaros, K., Augustyniak, C., Bennett, C. L., Tallman, M. S., Variakojis, D., Winter, J. N. & Gordon, L. I., Jun 1 2007, In : British Journal of Haematology. 137, 6, p. 545-552 8 p.

Research output: Contribution to journalArticle

66 Scopus citations

Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma

Zhang, G. S., Winter, J. N., Variakojis, D., Reich, S., Lissner, G. S., Bryar, P., Regner, M., Mangold, K. & Kaul, K., Mar 1 2007, In : Leukemia and Lymphoma. 48, 3, p. 577-583 7 p.

Research output: Contribution to journalArticle

29 Scopus citations